112 related articles for article (PubMed ID: 33640906)
1. Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD.
Dai H; Rachakonda SP; Penack O; Blau IW; Blau O; Radujkovic A; Müller-Tidow C; Dreger P; Kumar R; Luft T
Blood Cancer J; 2021 Feb; 11(2):42. PubMed ID: 33640906
[TBL] [Abstract][Full Text] [Related]
2. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease.
Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
4. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
Schroepf S; Kappler R; Brand S; Prell C; Lohse P; Glas J; Hoster E; Helmbrecht J; Ballauff A; Berger M; von Schweinitz D; Koletzko S; Lacher M
Inflamm Bowel Dis; 2010 Nov; 16(11):1882-90. PubMed ID: 20848514
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Kariminia A; Holtan SG; Ivison S; Rozmus J; Hebert MJ; Martin PJ; Lee SJ; Wolff D; Subrt P; Abdossamadi S; Sung S; Storek J; Levings M; Aljurf M; Arora M; Cutler C; Gallagher G; Kuruvilla J; Lipton J; Nevill TJ; Newell LF; Panzarella T; Pidala J; Popradi G; Szwajcer D; Tay J; Toze CL; Walker I; Couban S; Storer BE; Schultz KR
Blood; 2016 Jun; 127(24):3082-91. PubMed ID: 27020088
[TBL] [Abstract][Full Text] [Related]
6. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.
Croudace JE; Inman CF; Abbotts BE; Nagra S; Nunnick J; Mahendra P; Craddock C; Malladi R; Moss PA
Blood; 2012 Nov; 120(20):4246-55. PubMed ID: 23012327
[TBL] [Abstract][Full Text] [Related]
7. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.
Kitko CL; Levine JE; Storer BE; Chai X; Fox DA; Braun TM; Couriel DR; Martin PJ; Flowers ME; Hansen JA; Chang L; Conlon M; Fiema BJ; Morgan R; Pongtornpipat P; Lamiman K; Ferrara JL; Lee SJ; Paczesny S
Blood; 2014 Jan; 123(5):786-93. PubMed ID: 24363401
[TBL] [Abstract][Full Text] [Related]
8. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
9. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
Front Immunol; 2018; 9():2932. PubMed ID: 30619292
[TBL] [Abstract][Full Text] [Related]
10. Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.
Rachakonda SP; Penack O; Dietrich S; Blau O; Blau IW; Radujkovic A; Isermann B; Ho AD; Uharek L; Dreger P; Kumar R; Luft T
J Clin Oncol; 2014 Oct; 32(30):3421-7. PubMed ID: 25225421
[TBL] [Abstract][Full Text] [Related]
11. Biomarker Panel for Chronic Graft-Versus-Host Disease.
Yu J; Storer BE; Kushekhar K; Abu Zaid M; Zhang Q; Gafken PR; Ogata Y; Martin PJ; Flowers ME; Hansen JA; Arora M; Cutler C; Jagasia M; Pidala J; Hamilton BK; Chen GL; Pusic I; Lee SJ; Paczesny S
J Clin Oncol; 2016 Aug; 34(22):2583-90. PubMed ID: 27217465
[TBL] [Abstract][Full Text] [Related]
12. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
13. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
[TBL] [Abstract][Full Text] [Related]
14. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration.
Guo YC; Chiu YH; Chen CP; Wang HS
Stem Cell Res Ther; 2018 Oct; 9(1):281. PubMed ID: 30359318
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Zychowska M; Mika J
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3418-3437. PubMed ID: 30076959
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation.
Kim DH; Jung HD; Lee NY; Sohn SK
Transplantation; 2007 Oct; 84(7):917-25. PubMed ID: 17984846
[TBL] [Abstract][Full Text] [Related]
19. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
20. Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.
Partanen J; Hyvärinen K; Bickeböller H; Bogunia-Kubik K; Crossland RE; Ivanova M; Perutelli F; Dressel R
Front Immunol; 2020; 11():575492. PubMed ID: 33193367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
